Skip to main content

Posts

Forbes Top 25 for 2008

We are back with a new group of 25 rapidly growing technology companies, 12 of which are repeats from our prior list. One company, sixth-ranked Cognizant Technology Solutions (nasdaq: CTSH - news - people ), has appeared every year since the inception of the list six years ago. America's 25 Fastest-Growing Tech Companies More on America's 25 Fastest-Growing Tech Companies Our focus is on sales growth--we require at least 10% annualized sales gains over the past five years--but candidates for our list must be profitable over the past 12 months and have Thomson IBES consensus earnings forecasts of at least 10% annualized earnings growth over the next three to five years. Our only other financial hurdle is that we require at least $25 million in sales over the past four quarters. We exclude companies with significant legal problems or with possible accounting or corporate governance issues. For the last two items, we are guided by scores from Audit Integrity of Los Angeles. Toppin...

Forbes Fast 15

Company Business Price ($) Next 12-month P/E (%) Latest 12-month Sales ($) Sales Growth1 (%) EPS Growth2 (%) Ansys engineering simulation software 35.75 27 359 62 19 Atheros Communications semiconductors for communications 26.64 22 390 46 23 Bruker BioSciences precision instruments 11.52 38 499 23 25 Daktronics LED displays, scoreboards 22.27 27 470 25 22 Digi International computer equipment 12.88 17 173 20 15 Dionex analytical instruments, chemicals 81.57 30 337 14 18 FormFactor semiconductor testing equipment 26.36 16 440 29 21 Manhattan Associates supply chain management software 23.95 16 328 17 15 Macrovision digital rights management technology 17.13 11 273 16 16 Power Integrations high-voltage analog circuits 26.42 18 180 13 23 Progress Software business management software 30.45 16 494 10 15 Rimage digital media recording equipment 25.66 17 111 15 15 Sigma Designs semiconductors for digital media 43.34 16 176 150 24 SiRF Technology Holdings GPS technology 18.43 15 303 33 24 X-...

CREE reports new LED markets growing

Ahead of the Curve: Cree 08Q2 Earnings Review: LED Market Arriving?Font size: A | A | A8:26 AM ET 1/24/08 | Briefing.com reported their fiscal 2008 Q2 results after the close on Tuesday, January 22, 2008. While some might view the results as positive because Cree beat earnings estimates, the more significant positive news is the statements made about the nature of the market for commercial LED lighting. It is this market, we believe, that will eventually be the driver for Cree products. We recommend continued holding for those investors following our investment premise for the company. Exiting The Waiting Period After it became clear in August of 2006 that Cree's presence in the handset LED marketplace had weakened substantially, we declared that Cree had entered a "Waiting Period." The waiting period amounted to an unknown period of time before the market for commercialization of white LED products developed. While Cree itself would not be a vendor of application produ...

Briefing: Bargain Hunting: Corning 1/29/08

Manufacturer Corning (GLW 23.10, +0.73) delivered better than expected fourth quarter earnings results, posting a profit of $0.40 per share, excluding items, on a 16% increase in sales to $1.58 billion. In October the company guided for fourth quarter earnings per share in the range of $0.36 to $0.38 and sales of $1.50 billion to $1.55 billion. The strength in the period was driven by a 25% sales increase in its core Display Technologies segment, which prospered from continued strong global demand for LCD televisions and notebook computers. Telecommunications segment sales dropped 9.0% sequentially, yet that was owed to normal seasonality and was actually a bit better than the forecast for a 10% decline. Sales for the Environmental Technologies segment jumped 22% year-over-year while Life Sciences sales rose 4.0% Importantly, Corning provided some reassuring guidance for the first quarter. It expects sales in the range of $1.59 billion to $1.62 billion and earnings per share in the...

Introduction

What is a TRUM? Where does it come from? Is this a financial word? My interests are technology, sports and stocks, not necessarily in that order. In recent years, my sports interest has gotten me into fantasy sports. I've played in leagues for baseball, basketball, football, NCAA basketball tourney. Fantasy sports allows you the chance to behave and experience the life of being a Real General Manager. My love of numbers and statistics made playing these games fun on 2 accounts. Bringing a greater understanding of the game and the team contributions, it also lets you play with statistics to maximize your team strengths and understand its weaknesses. While playing fantasy sports, I came to reading many sports sites, blogs, etc. Anything to get an advantage and win. Well, what I found was a site called talentedmrroto.com. Matthew Berry is the creater and writer on the site. In the last year, he sold his site to ESPN and now, many folks can read him and watch him on ESPN. ...

Biogen BIIB - sees growth in 2008

Shares of Biogen Idec (BIIB 55.22) traded higher on Monday, gaining more than 3% in pre-market activity, after the Cambridge-based biotechnology company raised its guidance for fiscal 2007 and issued a positive outlook for the following year on sales of its newest multiple sclerosis drug Tysabri. Biogen, which has been struggling with slowing sales of its flagship drug Avonex and recently failed to attract bidders after putting itself up for sale in October, expects this year's earnings to be above the high-end of its previous guidance of $2.60 to $2.70 per share. The consensus estimate currently calls for earnings of $2.62 per share. For 2008 earnings, the company forecast earnings of $3.20 to $3.35 per share, excluding special items, with revenue growth between 15% and 20% on sales of its new multiple sclerosis drug Tysabri. Analysts are currently expecting earnings of $3.20 per share. Biogen also announced new data on the global utilization, safety and overall patient expos...

Etrade - possibly a buy at 2.40

With its stock depressed to multi-year lows, E*Trade Financial (ETFC) announced earlier today its turnaround plan is gaining traction. Shares of the online brokerage firm are up more than 10% in pre-market trading in response. The company recently sold a combined $6.0 billion worth of asset-backed securities portfolios. The most recent sale included $3.0 billion worth of mortgage-backed securities and municipal bonds, which resulted in a loss of less than $5 million. E*Trade's home equity loan portfolio ended 2007 with less than $12 billion in balances. Management expects its 2007 year-end tier 1 capital ratio to be equal to or better than 5.9%. A firm is considered well-capitalized if its ratio is at least 6%. The company's efforts to reduce risk and strengthen its relative capital position bode well for investors awaiting a turnaround. Notably, management has decided to discontinue its institutional trading business as part of an effort to return to its core competencies...